We are live on ! Find out more
APOPW

Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW

Delisted

APOPW was delisted on the 3rd of August, 2021.

Back to rankings

2 hedge funds and large institutions have $42K invested in Cellect Biotechnology Ltd. Warrants to Purchase ADRs in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

91% more capital invested

Capital invested by funds: $22K → $42K (+$20K)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$21.4K
2
UBS Group
UBS Group
Switzerland
+$1.1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$41K +$21.4K +9,747 +93%
UBS Group
2
UBS Group
Switzerland
$1K +$1.1K +500 New

APOPW Hedge Fund Activity: Q3 2017 in Review

2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) for Q3 2017, worth a combined $42K — up 91% from $22K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new APOPW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $21.4K.

  • 2 institutional investors held Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) as of Q3 2017, up from 1 in Q2 2017.
  • Funds reported $42K of Cellect Biotechnology Ltd. Warrants to Purchase ADRs stock for Q3 2017, up 91% quarter-over-quarter.
  • 1 fund opened new Cellect Biotechnology Ltd. Warrants to Purchase ADRs positions in Q3 2017 and 0 closed out, a net change of +1 holder.
  • The largest Cellect Biotechnology Ltd. Warrants to Purchase ADRs buyer in Q3 2017 was Susquehanna International Group, an estimated $21.4K added.

Based on aggregated 13F filings for Q3 2017.